IL-23

DRUG2 trials

Sponsors

University of Maryland, Baltimore, Specialty Networks Research.

Conditions

Crohn Disease (CD)HealthySchizo Affective DisorderSchizophreniaUlcerative Colitis (UC)

Phase 4

Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia

Not yet recruitingNCT07615075

University of Maryland, BaltimoreHealthy, Schizo Affective Disorder, Schizophrenia

Start: 2026-09-01End: 2030-09-01Target: 40Updated: 2026-05-29

INSIGHT-IBD Pragmatic Study

Not yet recruitingNCT07686757

Specialty Networks Research.Crohn Disease (CD), Ulcerative Colitis (UC)

Start: 2026-06-01End: 2028-06-01Target: 400Updated: 2026-07-07